CVE-2026-78211 4MOSAn Security Technology CVE debrief

Who should care

Defenders responsible for 4MOSAn GCB Doctor deployments should assess exposure and prioritize patching or compensating controls. This includes operators, platform administrators, vulnerability management teams, and security teams who need to verify deployments, assess potential impact, and implement necessary controls.

Why it matters

CVE-2026-78211 is a critical OS Command Injection vulnerability in 4MOSAn GCB Doctor that allows unauthenticated remote attackers to execute arbitrary system commands on the server. Defenders responsible for 4MOSAn GCB Doctor deployments should assess exposure and prioritize patching or compensating controls.

• Potential execution of arbitrary system commands on the server
• Possible disruption of critical systems and services
• Potential data breaches or unauthorized access
• Need for verification of 4MOSAn GCB Doctor deployments and patching or compensating controls

Technical summary

The 4MOSAn GCB Doctor developed by 4MOSAn Security Technology has a critical OS Command Injection vulnerability. Unauthenticated remote attackers can inject malicious commands through an unremoved ADOdb test page parameter, allowing execution of arbitrary system commands on the server. This vulnerability allows potential execution of arbitrary system commands, possible disruption of critical systems and services, and potential data breaches or unauthorized access. Defenders should prioritize verifying exposure of 4MOSAn GCB Doctor deployments and assess the need for patching or compensating controls.

Defensive priority

Defenders should prioritize verifying exposure of 4MOSAn GCB Doctor deployments and assess the need for patching or compensating controls.

Recommended defensive actions

• Verify 4MOSAn GCB Doctor deployments for exposure
• Assess the need for patching or compensating controls
• Monitor for potential exploitation attempts
• Review compensating controls for exposed systems
• Check relevant monitoring, detection, and logs for exposed assets
• Track exceptions, retest remediated assets, and close the item only after evidence is documented
• Confirm whether affected product deployments exist in managed environments and assign an owner for follow-up

Evidence notes

The CVE record and NVD detail page provide information on the vulnerability, but vendor confirmation and additional details are limited. Defenders should verify 4MOSAn GCB Doctor deployments and assess exposure. Limited source detail exists, so explicit evidence limits and defensive verification tasks are required. No additional facts beyond source-provided information can be confirmed.

Sources and references

Methodology and review provenance

AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.